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Background
• Osteoporosis, a skeletal disease, is a serious public health problem with an 
estimated 1.4 million Canadians and 10 million Americans affected.
• The epidemiological and clinical importance lies in the resulting fractures.
• The routine management of osteoporosis should target all aspects of the 
disease, including maximizing and preserving bone mass and preventing 
future fractures through pharmacotherapy and lifestyle modification. 
• Despite strong evidence-based rationale for both the primary and secondary 
prevention of osteoporosis, there remains an overall low prevalence of 
osteoporosis treatment in older adults. 
Cohort Selection 




• Low treatment rate prior to incident fracture (15% 
of the sample).
• Treatment rate improved to 19% following the 
index fracture.
• Those who received treatment following the 
fracture were significantly younger, more often 
female, and had fewer co-morbid conditions (p < 
Materials & Methods
• To determine if older adults with 
multiple co-morbid conditions 
were less likely to receive 
osteoporosis treatment following 
an incident osteoporosis 
fracture than younger healthier 




• Retrospective nested cohort study.
Data Sources
• There is some question whether low treatment rates in older adults are simply 
age related variations (in treatments) or due to the presence of co-morbid 
conditions. 
Variable





Age category (years) .000
65–69 1 (reference)
70–74 1.12 (0.86 – 1.47) 0.389
75–79 0.96 (0.75 – 1.24) 0.777
80–84 0.90 (0.70 - 1.16) 0.414
85–89 0.64 (0.49 - 0.83) 0.001
≥ 90 0.47 (0.35 - 0.63) 0.000
Sex 0.000
Female 1 (reference)
Male 0.23 (0.19–0.29) 0.000
Charlson-Deyo Index (CDI) 0.000
≤ 1 1 (reference)
2–3 0.83 (0.73–0.94) 0.003
≥ 4 0.63 (0.48–0.83) 0.001
Fracture site 0.000
Hip 1 (reference)
Arm / Wrist 1.10 (0.93 – 1.32) 0.273
Pelvis 1.27 (1.01 – 1.60) 0.039
Vertebrae 2.64 (2.12 – 3.29) 0.000
Ribs 1.01 (0.69 – 1.46) 0.976
Health Authority 0.000
Results: Patient Characteristics *
0.001).
• The treatment rate improved significantly every 
year (p < 0.001).
• Patients residing in more central health regions 
received treatment significantly more often than 
those residing in the Northern region (p < 0.001).
• Age, sex, co-morbidity (CDI), fracture site, and 
health region were all significantly associated with 
the dispensation of an osteoporosis medication 
within six months following the index fracture.
Those with ≥ 4 co-
morbidities were 1.6 times 
less likely to have been 
dispensed treatment
Subjects ≥ 90
years were dispensed 
medication less than 50% of 
the time compared to subjects 








• De-identified administrative healthcare data derived from the British 
Columbia (Canada) Linked Health Database (BCLHD).
• Data bases used: Prescription data (PharmaCare) and hospital separations 
(Discharge Abstract Database [DAD]). 
Study Population
• All residents in the province of BC, Canada aged 65 years and older who 
had continuous enrolment in the PharmaCare prescription benefits plan 
between 1999 and 2002.
Outcome Measures
• Dependent variable - osteoporosis medication dispensation. 
• Independent variables (main)- age and co-morbidity (CDI). 
• Covariates - sex, fracture site, year of fracture, health region, and 
osteoporosis treatment prior to the index fracture. 
Statistical Analysis
• Using multivariate logistic regression techniques, we used the Enter 
procedure in which all independent variables are entered in a single step and 
then tested for the possibility of statistical interaction between the main 
independent variables (age and CDI score) and all other covariates.  
• We pre- specified that we would consider only interaction terms that 
achieved a level of statistical significance of p < 0.10. 
• The calculated ORs were considered statistically significant if the 95% CI did 
not include 1.
Despite the wide availability of osteoporosis 
medications, our findings suggest that the 
majority of older adults, many of who have at 
least one co-morbid condition, are not 
receiving treatment to prevent the 
progression of the disease and to prevent 
further fractures. 
Conclusions
Vancouver Coastal 1 (reference)
Interior 0.68 (0.58 – 0.80) 0.000
Fraser 0.92 (0.80- 1.07) 0.287
Vancouver Island 0.69 (0.59 – 0.81) 0.000
Northern 0.48 (0.35 – 0.67) 0.000
Missing 0.71 ( 0.39 – 1.32) 0.282
Prior treatment .000
No treatment 1 (reference)
Prior treatment 15.89 (9.69 – 26.04) 0.000






Those with a 
fractured vertebrae 
were 2.64 times 











Charlson-Deyo Index (CDI) †
≤ 1 7,599 (63.2)
2–3 3,724 (31)







Island 2,531  (21.0)
Northern 525 (4.4)
Unknown 109 (0.9) 65–69 70–74 75–79 80–84 85–89 ≥ 90
Male 383 509 629 592 561 343













Age and Sex †
* All data are shown as number (percentage)
† p < 0.001 for chi square differences between categories within group
